Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.
Journal article
Bastard P. et al, (2022), The Journal of experimental medicine, 219
Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study.
Journal article
Yao P. et al, (2022), BMJ open, 12
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
Journal article
Närhi F. et al, (2022), The Lancet Digital Health, 4, e220 - e234
Vitamin D Deficiency and Its Association with Iron Deficiency in African Children
Journal article
Mogire RM. et al, (2022), Nutrients, 14, 1372 - 1372
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Journal article
Tomic A. et al, (2022), Nature communications, 13
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Journal article
Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Journal article
Fisher BA. et al, (2022), The Lancet Respiratory Medicine, 10, 255 - 266
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.
Journal article
Otter AD. et al, (2022), Microbiology spectrum, 10
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2022), The Lancet, 399, 665 - 676
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Response to Letter to the Editor by Ish et al. entitled ‘COVID-19 vaccine equity—the need of the hour’
Journal article
Maclean P. et al, (2022), QJM: An International Journal of Medicine
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2022), The Lancet, 399, 143 - 151
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number
Journal article
Keeling MJ. et al, (2022), Statistical Methods in Medical Research
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2021)
Why do breakthrough COVID-19 infections occur in the vaccinated?
Journal article
Maclean P. et al, (2021), QJM : monthly journal of the Association of Physicians
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Journal article
Townsend A. et al, (2021), Nature Communications, 12
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Journal article
Peng Y. et al, (2021), Nature Immunology
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Journal article
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
Mapping the human genetic architecture of COVID-19.
Journal article
COVID-19 Host Genetics Initiative None., (2021), Nature, 600, 472 - 477